Table 2.
Median and range of the grouped sub-scores (Voiding and Incontinence) and the individual symptom scores for nocturia, urgency and frequency from the ICIQ LUTS questionnaires (MLUTS and FLUTS for males and females respectively) by treatment, with p-values and standardized effect size, d
| Measure | Treatment | |||||
|---|---|---|---|---|---|---|
| A: Placebo | B: Melatonin | p | d | |||
| Median | Range | Median | Range | |||
| Voiding sub-score | 4.0 | 0–12 | 2.0 | 0–12 | 0.096 | 0.492 |
| Incontinence (Storage) sub-score | 3.0 | 0–9 | 3.0 | 0–12 | 0.107 | 0.450 |
| Nocturia | 2.0 | 1–3 | 2.0 | 1–3 | 0.892 | 0.037 |
| Urgency | 2.0 | 0–3 | 2.0 | 1–4 | 0.772 | 0.079 |